A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2002
11/27/2002	EP1259640A2 Methods and compositions for the screening of cell cycle modulators
11/27/2002	EP1259638A2 Methods for selectively modulating survivin apoptosis pathways
11/27/2002	EP1259626A2 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators
11/27/2002	EP1259621A2 Lipid metabolism enzymes
11/27/2002	EP1259618A2 Human enzyme molecules
11/27/2002	EP1259614A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/27/2002	EP1259611A2 G-protein coupled receptors
11/27/2002	EP1259609A2 Human schizophrenia gene
11/27/2002	EP1259608A1 Modified fluorescent proteins
11/27/2002	EP1259606A2 Compositions useful for regulating parkin gene activity
11/27/2002	EP1259598A2 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
11/27/2002	EP1259595A2 Integrin antagonists
11/27/2002	EP1259550A1 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
11/27/2002	EP1259546A1 Ccr2-64i, polymorphic variant of the human ccr2 receptor and its use in the diagnostic and treatment of atherosclerosis
11/27/2002	EP1259544A2 Heterologous polypeptide of the tnf family
11/27/2002	EP1259530A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof
11/27/2002	EP1259494A1 Aryloxyacetic acids for diabetes and lipid disorders
11/27/2002	EP1259292A2 Therapeutic agents
11/27/2002	EP1259269A1 Agent for the treatment of wounds
11/27/2002	EP1259260A1 Combination therapy for the treatment of inflammatory and respiratory diseases
11/27/2002	EP1259255A1 Pai-2 conjugates for the treatment and imaging of cancer
11/27/2002	EP1259248A1 Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor d
11/27/2002	EP1259247A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4)
11/27/2002	EP1259246A2 Use of dpp-iv inhibitors for the treatment of diabetes
11/27/2002	EP1259243A2 Bupropion metabolites and methods of their synthesis and use
11/27/2002	EP1259242A2 Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
11/27/2002	EP1259240A2 Agents, such as nicotinamide or cadpr for the treatment of skin disorders
11/27/2002	EP1259239A2 Use of cox-2 inhibitors as gastroprokinetics
11/27/2002	EP1259237A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug
11/27/2002	EP1259236A1 Tyrosine kinase inhibitors
11/27/2002	EP1259235A1 Tyrosine kinase inhibitors
11/27/2002	EP1259234A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
11/27/2002	EP1259233A1 Modulation of bone formation
11/27/2002	EP1259230A2 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure
11/27/2002	EP1259229A2 Use of pde v inhibitors
11/27/2002	EP1259223A1 Protein matrix materials, devices and methods of making and using thereof
11/27/2002	EP1259222A1 Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
11/27/2002	EP1259190A2 Method for making, loading and sealing a cell or drug encapsulation device, and such a device
11/27/2002	EP1259128A1 Water containing soluble fiber
11/27/2002	EP1259126A1 Strengthening natural healing drink
11/27/2002	EP1259121A2 Weight loss induced by reduction in neuropeptide y level
11/27/2002	EP1180164A4 Methods using of fab i and compounds modulating fab i activity
11/27/2002	EP1107795B1 Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
11/27/2002	EP1093369B1 Agent with an antidepressive effect comprising pramipexole and sertraline
11/27/2002	EP1083929A4 The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
11/27/2002	EP0994887B1 Modified glycosides, compositions comprised thereof and methods of use thereof
11/27/2002	EP0910360B1 Reduction of cardiotoxicity of an antitumor agent using manganese compound
11/27/2002	CN1382157A Therapeutic compounds comprised of anti-FC receptor binding agents
11/27/2002	CN1382156A PABLO polypeptide that interacts with BCL-XL and uses related thereto
11/27/2002	CN1382053A Novel hormonal composition and use thereof
11/27/2002	CN1382052A Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders
11/27/2002	CN1382047A Neurotherapeutic clavulanate composition and method
11/27/2002	CN1382044A Use of cell factor inhibiting anti-inflammatory agent in rhinovirus infection
11/27/2002	CN1382042A Treatment of emphysema using RAR selective retinoid agonists
11/27/2002	CN1381280A Introduced suppository and its application method
11/26/2002	US6486350 Biological reagents and methods for determining the mechanism in the generation of β-amyloid peptide
11/26/2002	US6486322 Azaindole derivatives, process for their preparation, and their use as antitumor agents
11/26/2002	US6486305 Method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
11/26/2002	US6486209 Use for 1,3-propanediol derivatives
11/26/2002	US6486208 Sustained release, and comfortable opthalmic composition and method for ocular therapy
11/26/2002	US6486207 Compositions and methods for amelioration of human female sexual dysfunction
11/26/2002	US6486206 Mechanical and pharmacologic therapies to treat cardiac arrest
11/26/2002	US6486188 Method of treatment for cardiovascular complications
11/26/2002	US6486179 Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
11/26/2002	US6486177 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
11/26/2002	US6486165 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/26/2002	US6486152 Topical carbamazepine formulations and methods of use
11/26/2002	US6486142 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
11/26/2002	US6486141 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
11/26/2002	US6486138 Ophthalmic compositions containing galactomannan polymers and borate
11/26/2002	US6486136 Combinations comprising VX478, zidovudine and/or 1592U89 for use in the treatment of HIV
11/26/2002	US6486127 Compositions comprising D-chiro inositol and lipid lowering compounds and methods of treatment thereof
11/26/2002	US6485973 Oligonucleotides specific for the marORAB operon
11/26/2002	US6485957 DNA encoding the human serine protease EOS
11/26/2002	US6485934 Regulatory system for inducible expression of genes with lambdoid promoters
11/26/2002	US6485929 Method for inhibiting CD95-independent apoptosis in AIDS
11/26/2002	US6485919 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
11/26/2002	US6485758 Charcoal, vitamin b6, ma huang (herb containing ephedrine) and inert, nontoxic carrier
11/26/2002	US6485755 Methods of using electron active compounds for managing cancer
11/26/2002	US6485752 Rose hip extract and fish oil for the treatment of pain and stiffness in the joints, such as associated with osteoarthritis
11/26/2002	US6485733 Absorbent article composition for sequestering skin irritants
11/26/2002	CA2240717C Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
11/26/2002	CA2111573C Cadherin materials and methods
11/24/2002	CA2354921A1 Drug evolution: drug design at hot spots
11/23/2002	CA2386740A1 Combination treatment for alcoholism and alcohol dependence
11/21/2002	WO2002093176A2 Methods for identifying compounds for treatment of ibd
11/21/2002	WO2002092854A2 Genes expressed in breast cancer as prognostic and therapeutic targets
11/21/2002	WO2002092849A2 Methods
11/21/2002	WO2002092840A2 Agents that regulate apoptosis
11/21/2002	WO2002092831A2 Method for identifying ligands for g protein coupled receptors
11/21/2002	WO2002092817A1 Functions for d52 and ra006 nucleic acids and polypeptides
11/21/2002	WO2002092788A2 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
11/21/2002	WO2002092782A2 Diagnosis and treatment of malignant neoplasms
11/21/2002	WO2002092771A2 Specific binding proteins and uses thereof
11/21/2002	WO2002092764A2 Transgenic animal model of bone mass modulation
11/21/2002	WO2002092762A2 Cytokine polypeptides
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092623A1 INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF
11/21/2002	WO2002092617A1 Combined approach to treatment of cancer using a c-myc antisense oligomer
11/21/2002	WO2002092616A1 Antisense permeation enhancers

1 ... 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 ... 1151